ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A)

Clinical trials for ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A) explained in plain language.

Never miss a new study

Get alerted when new ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A) trials appear

Sign up with your email to follow new studies for ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New injection aims to tackle hidden heart risk

Disease control Not yet recruiting

This Phase 2 trial tests an experimental injection called SYH2068 in 120 adults with high lipoprotein(a), a genetic risk factor for heart disease. Participants receive either the drug or a placebo to see if it safely lowers their Lp(a) levels over several months. The goal is to f…

Matched conditions: ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A)

Phase: PHASE2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:08 UTC

ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A)

Get alerted when new ADULT PARTICIPANTS WITH ELEVATED LIPOPROTEIN(A) trials appear

New injection aims to tackle hidden heart risk